<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>CLINICAL AND LABORATORY ASSESSMENT OF RENAL DYSFUNCTION IN LIVER CIRRHOSIS</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Anagul</mods:namePart><mods:namePart type="family">Samadova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>The study investigated the significance of clinical and laboratory parameters and cystatin C levels in assessing renal dysfunction in patients with liver cirrhosis. A total of 90 patients and 30 healthy controls were examined. Patients with renal dysfunction showed significantly increased creatinine, urea, and cystatin C levels, with a decreased glomerular filtration rate (p&amp;lt;0.05). Cystatin C demonstrated a negative correlation with GFR and a positive correlation with creatinine and urea. The findings suggest that cystatin C may serve as an additional marker for early detection and prognostic evaluation of hepatorenal syndrome</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-02-16</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>South Aral Region Medical Journal</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>